H
EW icon

Hexavest’s Edwards Lifesciences EW Stock Holding History

Hexavest’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$120K Buy
1,056
+905
+599% +$103K 0.01% 211
2021
Q2 		$16K Sell
151
-38
-20% -$3.58K ﹤0.01% 291
2021
Q1 		$16K Hold
189
– – ﹤0.01% 298
2020
Q4 		$17K Hold
189
– – ﹤0.01% 305
2020
Q3 		$15K Hold
189
– – ﹤0.01% 335
2020
Q2 		$13K Hold
189
– – ﹤0.01% 354
2020
Q1 		$12K Buy
+189
New +$13.6K ﹤0.01% 375

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Hexavest's EW Position: Q3 2021 in Review

Hexavest increased its Edwards Lifesciences (EW) stake by 599% in Q3 2021, buying an estimated $103K and bringing the position to 1,056 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #211.

Hexavest first reported a position in EW in Q1 2020 and has held it in 7 quarters since. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Hexavest held 1,056 shares of Edwards Lifesciences worth $120K as of Q3 2021.
  • Hexavest bought 905 Edwards Lifesciences shares in Q3 2021, an estimated $103K.
  • Edwards Lifesciences made up 0.01% of Hexavest's portfolio in Q3 2021, its #211 holding.
  • Hexavest first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 7 quarters since.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.